Global Fabry Disease Market Published: November 2014 Single User PDF: US$ 2500 Corporate User PDF: US$ 3500 Order this report by calling or Send an to with your contact details and questions if 1© ReportsnReports.com / Contact

Global Fabry Disease Market Fabry disease is an inheritable lysosomal storage disease characterized by the excessive accumulation of globotriaosylceramide (GL-3) in lysosomes. It results from a deficiency of a-Gal and can result in symptoms such as fatigue, angiokeratoma, tinnitus, kidney failure, heart disorders, and nervous system problems. Fabry disease results from mutations in the galactosidase (GLA) gene, resulting in decreased activity or complete absence of a-Gal. Fabry disease resulting from the decreased activity of the enzyme is called later-onset Fabry disease. This form of the disease can effect both males and females. The symptoms of this disease typically appear during adulthood and usually focus on a single organ. Fabry disease resulting from the complete absence of a-Gal results in a more severe form called classic Fabry disease. The classic form of the disease usually affects males. The disease symptoms usually starts in adolescence and include clouded eye lenses, skin lesions, pain, and reduced sweating. If untreated, the disease can lead to cardiac dysfunction, renal failure or stroke, often resulting in death during fourth or fifth decade of life. Analysts forecast the Global Fabry Disease market to grow at a CAGR of percent over the period Complete Report disease-market htmlhttp:// disease-market html Order this report by calling or Send an to with your contact details and questions if any. 2© ReportsnReports.com / Contact

Global Fabry Disease Market Covered in this Report This report covers the present scenario and the growth prospects of the Global Fabry Disease market for the period To calculate the market size, the report considers the revenue generated from the sales of various innovator drugs available in the market for the treatment of fabry disease. Global Fabry Disease Market , has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Fabry Disease market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Key Regions Americas APAC & EMEA Single User License Available US $ 2500 Order a copy of this report Key Vendors Genzyme, Shire Other Prominent Vendors Amicus Therapeutics, Green Cross Corporation, ISU Abxis, JCR Pharmaceuticals, Protalix, iotherapeutics Order this report by calling or Send an to with your contact details and questions if any. 3© ReportsnReports.com / Contact

Global Fabry Disease Market Market Driver Special Provisions for Orphan Drugs Market Challenge Limited Patient Population Market Trend Regulatory Assistance in Emerging Countries Key Questions Answered in this Report What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? Inquire for this Order this report by calling or Send an to with your contact details and questions if any. 4© ReportsnReports.com / Contact

Global Fabry Disease Market Table of Contents 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Disease Overview 06. Introduction 07. Market Landscape 08. Market Segmentation by Cell Line Used for Manufacturing the Drug 09. Geographical Segmentation 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Trends and their Impact 17. Vendor Landscape 18. Pipeline Analysis 19. Fabry Registry 20. Key Vendor Analysis 21. Other Reports in this Series Inquire for Order this report by calling or Send an to with your contact details and questions if any. 5© ReportsnReports.com / Contact